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INTRODUCTION 
 Vasculitis is inflammatory process affecting the vessel walls and leading 
to its compromise or destruction and subsequent hemorrhagic and ischemic 
events. Vessels of any organ can be affected that results in a wide variety of 
signs and symptoms1,2 The unique feature of this group is multiorgan 
involvement. Because of the rich vasculature, the skin is prone to be frequently 
affected in vasculitis.  
  Cutaneous involvement in vasculitides may be primary or reflector of a 
fatal systemic disease or evidence of association with some other systemic 
disorder. Cutaneous vasculitic lesions offer a window to diagnosis and a ready 
source of accessible tissue for histopathologic examination. 
 Small vessel vasculitis is defined as one which affects mostly vessels 
smaller than arteries such as arterioles, capillaries and venules3. These 
heterogeneous clinical manifestations, combined with the etiologic non 
specificity of the histologic lesions, complicate the diagnosis of specific form of 
vasculitis.The gold standard for a diagnosis of vasculitis is histologic 
confirmation on biopsy, as few forms of vasculitis have a pathognomonic 
laboratory or imaging finding. As a clinicopathological process, vasculitis 
occurs both as a primary process or idiopathic vasculitis and as a secondary 
feature of other diseases such as collagen vascular diseases, infectious disorders, 
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malignancy and adverse drugs reaction. Many times the initial presentation of 
vasculitis is on the skin and it is the dermatologist who must diagnose and treat 
this challenging condition. 
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REVIEW OF LITERATURE 
Classification 
In 1952, Zeek- based upon vessel size and histopathology4, 5, 6 
Gilliam and Smiley in 19767- by subdividing Zeek's existing categories 
In 1990, American College of Rheumatology (ACR) - based upon clinical, 
laboratory, and histologic criteria, and those of the Chapel Hill Consensus 
Conferences - based mainly upon histologic criteria8, 9. 
An attempt to present a working classification has been previously presented by 
 Jorizzo in 1993  and  others 10, 11. 
Proposed working classification of vasculitis [updated version of Gilliam’s 
1976 scheme] 12. 
Small vessel vasculitis 
Cutaneous small vessel vasculitis – not further classified 
Henoch – Schonlein purpura 
Essential mixed cryoglobulinemia 
Waldenstroms hypergammaglobulinaemic purpura 
Associated with collagen vascular disease 
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Urticarial vasculitis 
Erythema elevatum diutinum 
Eosinophilic vasculitis 
Rheumatoid nodules 
Reactive leprosy 
Septic vasculitis 
Etiology 
Bacterial antigens may be noted in the wall of the small vessels, as may 
hepatitis B antigen13, 14. Still, as in all forms of vasculitis, most cases of small 
vessel vasculitis are idiopathic (45-54%), due to medications (10-45%), 
infections (10-36%), including hepatitis B (5%)13-16. Medications most 
commonly associated with small vessel vasculitis are antibiotics and NSAIDS 
(especially beta-lactams) and diuretics. Upper respiratory tract infections were 
the most common (20%) infectious cause of small vessel vasculitis in one series 
from Spain14.  
 Autoimmune diseases associated with secondary small vessel vasculitis 
include rheumatoid arthritis and systemic lupus erythematosus13-16 .Examples of 
implicated drugs induce vasculitis are aspirin, penicillin, thiazides, and 
sulphonamides. Examples of infective agents more often associated with 
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necrotizing venulitis are hepatitis B, streptococcal agents, and mycobacterium 
tuberculosis. Diseases associated with immune-complex formation include 
malignancies, connective tissue diseases, inflammatory bowel disease, and 
chronic active hepatitis13, 17. 
Pathogenesis 18, 11, 19 
  Antigenic triggers of immunological responses targeted at components of 
blood vessel walls elicit most vasculitides. The deposition of immune 
complexes in blood vessel walls is the best characterized mechanism for the 
vascular injury associated with vasculitis 18. Potential antigens of relevance 
include bacteria, viruses, drugs and other chemicals. The circulating immune 
complexes interact with the complement system to generate C3a, C5a, 
anaphylotoxins which stimulate the production of chemotactic factors and 
subsequent chemotaxis , the release of vasoactive amines (histamine) and the 
release of proinflammatory cytokines which induce expression of adhesion 
molecules subsequently,  immune complex with a sedimentation coefficient 
greater than 19S are deposited in vessel walls.  
  Neutrophils get attracted to this site and these release lysosomal enzymes 
in an attempt to engulf the immune complexes. This causes degranulation and 
destruction of the neutrophils (leukocytoclasis) with release of collagenase and 
elastase, generation of reactive oxygen species, ultimately resulting in 
inflammation and bystander fibrinoid necrosis of vessel walls11, 19. 
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  It is of practical importance to appreciate that neutrophils degrade 
immune complexes within 24 – 48 hours they are deposited20 usually within 24 
hours. Hence direct immunofluorescence of vasculitis lesions older than 3 – 12 
hours will generally yield negative results11, 21. 
Phenotypic manifestations of cutaneous lesions due to small vessel 
vasculitis 
•  The signs and symptoms of small-vessel vasculitis are extremely varied, 
and many are shared by all vessel vasculitis Presentation:  
o usually:  
 erythematous macules,  
 palpable purpura – hall mark feature, initial lesion non 
palpable becomes pustule or sometimes ulcerate. 
o may also be:  
 nodules22 
 hemorrhagic vesicles and bullae 
 crusted ulcers23,24 
  gangrene, infarct 
less commonly:  
 livedo reticularis 
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 pustules32 
 annular lesion26,29 
o lesions:  
 1mm to several cm diameter 
 sometimes painful30/ itching 
 may be:  
 single crop that subsides spontaneously after few 
weeks 
 crops at different stages of evolution that recur 
intermittently31 
• Location:  
o predilection for dependent parts:  
 particularly lower legs32,33 
o rarely in previously traumatized skin:  
 Koebner phenomenon34 
• Extracutaneous manifestations:  
o ≈20% of affected individuals 
o include:  
 arthralgia (synovial) (polyarthritis) 
 myositis 
 low-grade fever 
 malaise32, 35 
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o less commonly: 28,11,36,37,38 
 renal - glomeruli (proteinuria or hematuria) 
 gastrointestinal (abdominal pain or gastrointestinal bleeding) 
 pulmonary 
 neurological32,39 - focal or diffuse, central, or peripheral 
neurologic involvement. 
o not predicted by severity of histopathological changes40,35 
Laboratory findings 
These are both to confirm the diagnosis and to determine the extent of 
systemic vasculitis, or the existence of underlying associated diseases. 
Histopathology 
A definitive diagnosis of vasculitis requires histological confirmation in 
almost all cases. The hallmark histopathologic pattern of small vessel vasculitis 
is leukocytoclastic vasculitis. 
• Dynamic:  
o not all features necessarily present at a particular stage30 
o lesion of 18–24 hours’ duration shows most diagnostic features41 
• Usually in small venules (postcapillary venules) in dermis:  
o in severe cases may involve arterioles 
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Features  
 Neutrophil infiltration of vessel walls and extending into and beyond 
perivascular zone, neutrophils degenerate (leukocytoclasis) with formation of 
nuclear dust. 
Walls thickened by:  
 Exudate of inflammatory cells and due to edema fluid and due to 
exudation of fibrin (‘fibrinoid necrosis') which often extends into adjacent 
perivascular connective tissue. 
 Endothelial cells:  
 Usually swollen, some degenerate. 
Sometimes thrombosis can occur. 
Variable:  
o edema 
o extravasation of red blood cells 
 Sometimes eosinophils and lymphocytes:  
 perivascular 
 longer duration lesions 
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Other Changes 
• Macrophages scattered in interstitium:  
o even in early stages 
o time-dependent increase42 
• Mixed inflammatory cell infiltrate of eosinophils, lymphocytes and 
occasional neutrophils:  
o common in vasculitis due to drugs43 
Resolving Lesions33 
• Usually only mild perivascular infiltrate of lymphocytes and some 
eosinophils 
• May be rare plasma cell 
• Late resolving lesions:  
o hypercellular (busy) dermis striking feature with increased number 
of:  
 interstitial fibroblasts 
 histiocytes  
• Sometimes mild increase in acid mucopolysaccharides:  
o gives vague ‘necrobiotic’ appearance 
• Uncommonly, pronounced subepidermal edema results in vesiculobullous 
lesions 
• Cutaneous infarction:  
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o usually involving only epidermis and upper third of dermis 
 may follow thrombosis of affected vessels 
  A lymphocytic form (in which lymphocytes predominate) has also been 
described. There is still not enough evidence, however, to prove that the 
lymphocyte pattern is truly etiologically or clinically relevant. Old lesions of 
small vessel vasculitis may no longer demonstrate leukocytoclastic vasculitis 
and may contain mainly lymphocytes around blood vessels44-48. This latter 
consideration stresses the importance of timing when taking a biopsy in a 
dynamic process such as the vasculitic one. 
Cutaneous lymphocytic vasculitis 
 This form of vasculitis is characterized by lymphomonocytic cell 
infiltration as a primary response to various antigens such as medications or 
antigens found in connective tissue diseases such as lupus erythematosus, 
primary Sjögren's syndrome. These inflammatory cells are present in the 
involved vessel wall, while fibrinoid necrosis and leukocytoclasis is absent. 
Activated lymphocytes elaborate cytokines, thereby damaging the vessel wall, 
either by direct action of the cytokine or promotion of apoptosis. This form of 
vasculitis is infrequent but poorly studied 49,50, 2,51. 
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Drug-induced vasculitis  
  Drug-Induced vasculitis should be considered in any patient with small-
vessel vasculitis and will be substantiated most often in patients with vasculitis 
confined to the skin. Drug causes approximately 10 percent of vasculitic skin 
lesions. Drug-Induced vasculitis usually develops within 7 to 21 days after 
treatment begins 82, 32. Most common drugs include Beta – lactams, Penicillin, 
Sulfadrugs , Nonsteroidal anti- inflammatory drugs53. Identification of tissue 
eosinophilia in these biopsies is a clue to a drug etiology54. 
Henoch Schonlein purpura55-60 
 It comprises about 10 % of all cases of cutaneous vasculitis and the most  
Common  vasculitis in children ( 90 % of all cases)55,56. Upper respiratory tract  
infection precedes by 50% ,  in pediatric patients and 40% in adult patients. 
Other factors include drugs, malignancy, foods57, 58. The classic findings are 
palpable purpura, arthralgia and abdominal pain58, 59. Furthermore urticaria, 
vesicles, bullae and necrotic ulcers may develop.  
Henoch Schonlein purpura typically involving the extensor aspect of the 
limbs and buttocks in a symmetrical  fashion.  Henoch Schonlein purpura may 
also affect the trunk and face60. Renal involvement occurring in approximately 
30 – 90 % of patients and demonstrating only minimal proteinuria and 
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hematuria. Gastrointestinal bleeding being demonstrated in 50 – 75 % of 
patients.  
 USG Abdomen is indicated to exclude intussusceptions, bowel wall 
edema, thickening , or perforation. Arthritis is seen in about 75 % of patients, 
most frequently affecting the knees and ankles. ASO titre may be done to rule 
out streptococcal infection59. HSP is a clinical diagnosis, with conformation by 
direct immune fluorescence and routine histology. Histopathology shows 
leukocytoclastic vasculitis. Perivascular IgA deposits are characteristic of HSP.  
Essential Mixed Cryoglobulinemia 
 Cryoglobulins are immunoglobulins that precipitate in the cold and 
dissolve on reworming. Type II or essential mixed cryoglobulinemia, in which 
the cryoglobulin contains both a polyclonal IgG (Antigen)and a monoclonal 
IgM Rheumatoid factor directed against the IgG. Most cases are due to chronic 
infection with hepatitis C virus 61-65. 
 Although infection with hepatitis B virus and Epstein –Barr virus have 
been implicated in some patients61-67. Type III , in which there is also mixed 
cryoglobulin , but both the IgG and the rheumatoid factor IgM are 
polyclonal.this condition is often seen in chronic inflammatory and autoimmune 
disorders ( such as lupus and leukocytoclastic vasculitis), lymphoproliferative 
malignancies, and, in as many as one – half of cases, HCV infection 62,63,65,68. 
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The median age at diagnosis of cryoglobulinemia is early to middle sixth 
decade, with a female to male ratio of 2: 1 69.  
Recurrent showers of dependent palpable purpura associated with arthritis 
or arthralgia is the common presentation. Sometime cutaneous infarction may 
be the presenting feature. Histopathology shows the presence of hyaline thrombi 
in vessel wall with evidence of vessel wall damage. Conformation of 
cryoglobulins requires cryoglobulin test followed by serum protein 
electrophoresis69. 
Waldenstroms Hypergammaglobulinaemic Purpura 
 Its a polyclonal disorder most commonly linked with sarcoidosis, lupus 
erythematosus, sjogren syndrome and other auto immune conditions 71, 77. The 
majority of patients have positive anti nuclear antibody and anti- SSA (Ro) or 
anti –SSB (La) antibodies73-77. Other features associated include arthropathy, 
renal tubular acidosis, chest infections, lymphopenia and immune 
hypersensitivity pneumonitis. Most patients are female 78.  
 Clinically the pattern of purpura usually consisting of crops of small 
erythematous macular or palpable purpuric spots on the lower leg70-77. 
Prolonged walking, standing or sitting with the legs dependent, or other increase 
in venous pressure, may be an obvious provocative factor76,77. Histology may 
show vasculitic change, and DIF may show immunoglobulins in blood vessel 
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walls75,79, 80. There may be an abnormal ratio of IgG subclasses, with low 
IgG1/IgG2 ratio81. 
Vasculitis Associated With Collagen Vascular Diseases 
 Around 12% of cutaneous vasculitis cases will be associated with a 
connective tissue disorders55, 56. Secondary vasculitis due to connective tissue 
disease should be considered in patients presenting with biopsy – proven 
cutaneous vasculitis who have signs and symtoms of dry eyes, drymouth, 
arthritis, sclerosis, photosensitivity, or serologic evidence of ANA, RF, 
antiphospholipid antibodies, or anti- DNA, Ro, or La antibodies. Cutaneous 
vasculitis occurs frequently in SLE, RA and Sjogren syndrome, less commonly 
in dermatomyositis, scleroderma, and polychondritis55, 56, 82.  
 Increased or enhanced expression of vascular adhesion molecules 
attracting and activating neutrophils is suspected to play a role in the 
pathogenesis of connective tissue vasculitis83. In general, CTD vasculitis show 
more widespread organ involvement and the calibre of vessels affected shows 
more variation compared with conventional CLA. For example, lupus vasculitis 
patients represent a heterogenous population of which nearly 60% of cases do 
not fulfil the categories and definitions adopted by the CHCC84.  
 Small vessel vasculitis in LV patients is predominantly cutaneous84. LV 
patients are more likely to have livedo racemosa, anemia, elevated ESR, anti-La 
/ Sjogren syndrome (SS)-B antibodies than SLE patients without vasculitis. 
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Arterioles and post – capillary venules are the vessels most commonly affected 
by vasculitis, manifesting as purpura,  vesiculobullous lesions , urticaria , and 
splinter haemorrhages. 
 Skin biopsy will reveal a mixed, mostly small and less commonly 
muscular vessel neutrophilic vasculitis with lesions that can resemble either 
typical CLA or PAN. Extravascular histologies can provide clues to the 
diagnosis of CTD vasculitis such as the presence of interface dermatitis with 
dermal mucin deposition (found in SLE and Dermatomyositis), dermal and / or 
subcutaneous sclerosis in scleroderma, palisaded neutrophilic and 
granulomarous dermatitis in RA or SLE and tissue neutrophilia in SLE and 
Sjogren syndrome 85. 
Urticarial Vasculitis 
  Of patients with urticarial lesions, roughly 5-10% have urticarial 
vasculitius86, 87. It is a chronic disease, which presents as urticarial lesions that 
most often occur on the trunk or proximal limbs, frequently with associated 
angioedema88. Lesions differ from those of simple urticaria in that individual 
lesions persist for greater than 24hours, often demonstrate purpura and post 
inflammatory pigmentation, and cause symptoms of burning.  
 Two types described 1) UV associated with hypocomplementaemia  2) 
normocomplementaemic UV. Most UV patients are women (female to male 
ratio 3:2 to 4:1) in their fourth or fifth decade55. It is strongly associated with 
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connective tissue diseases (sjogren syndrome, SLE86, physical urticarias, 
hepatitis B or C, IgM or IgA gammopathies, serum sickness, colon cancer and 
drug ingestion. UV is thought to represent a type III hypersensitivity reaction, as 
circulating immune complexes may be demonstrated in upto 75% of patients89. 
Lesions of UV demonstrate leukocytoclastic vasculitis. 
Erythema Elevatum Diutinum 
EED is a rare chronic cutaneous eruption that is most commonly seen in 
adults. Though the exact etiology is unknown it has been associated with 
autoimmune diseases such as Rheumatoid arthritis, celiac disease, inflammatory 
bowel disease and type I diapetes mellitu, infections (streptococcus, hepatitis, 
syphilis, HIV 90-100. In addition it has been associated with 
hypergammaglobulinemia and IgA monoclonal gammopathies, myelodysplasia, 
pyoderma gangrenosum and relapsing polychondritis. The association with 
haematological disorders, such as multiple myeloma, is strong; however EED 
may precede the haematological disease by several years101. 
 Histopathology of acute lesions show leukocytoclastic vasculitis. 
Chronic lesions demonstrate fibrosis, capillary proliferations and infiltration of 
macrophages, plasma cellsand lymphocytes. Lesions of EED most commonly 
appear chronically in a symmetrical fashion over the dorsa of the hands, the 
knees, buttocks and Achilles tendons. They are red violaceous, red brown or 
yellowish papules, plaqus or nodules. These lesions may progress to form 
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atrophic scars. It may last from 5 to 35 years, with crops of new lesions 
developing every few weeks to months. 
Eosinophilic Vasculitis  
  Rare vasculitis, cause is unknown. Eosinophil cytokines such as IL-5, and 
toxic eosinophil granule proteins such as major basic protein, have been 
demonstrated in serum and tissues, respectively, and presumably play a part in 
the tissue damage. Neutrophil elastase is predominantly around vessels, and 
mast cell degranulation occurs. Eosinophilic vasculitis has also been reported in 
a patient with the hypereosinophilic syndrome. In this patient CD40 (a 
glycoprotein of the TNF receptor family) was considered to be important in 
pathogenesis 102.  
 Recurrent pruritic papules and urticarial lesions occur at any site, 
especially the head and neck, with angioedema of the face and extremities.   
Either sex and any age group may be affected. The course is long and recurrent 
but fever, arthralgia and visceral involvement are absent. Raynaud’s 
phenomenon and digital gangrene were reported in a patient with cutaneous 
eosinophilic vasculitis associated with the hypereosinophilic syndrome 102 
Histopathology shows fibrinoid deposition and necrosis of small dermal vessels 
with an infiltrate of eosinophils and absent or minimal leukocytoclasis. 
  Small vesicles containing eosinophils may be present. Immunoglobulin 
deposition is not a feature. This eosinophilic small vessel vasculitis is distinct 
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from other vasculitides such as CSS, in which medium to large vessels are 
affected. 
Rheumatoid Nodule 
 Palpable subcutaneous nodules occur in approximately 20% of patients 
with RA. The most common site is on ulnar border of the forearm.Less 
commonly ,they occur on the dorsa of the hands, on the knees, on the ears, over 
the scapulae. They vary in size upto several centimetres in diameter, are firm in 
cocsistency and tend to ulcerate with trauma. Nodules are almost invariably 
asocited with more severe forms of the disease, and rheumatoid factor and 
antinuclear factor are frequently found in the serum.  
 Nodules were characterized by granuloma formation secondary to 
leukocytoclastic vasculitis103. Histologically, rheumatoid nodules consists of 
fibrous tissue in which foci of fibrinoid necrosis are scattered, surrounded by a 
palisade of cells, mainly fibroblasts and histiocytes. A peripheral zone of 
lymphocytes and plasma cells occurs. Within the necrotic area are thin 
reticulum fibres, amorphous material and some nuclear debris are seen. 
Reactive Leprosy 
Erythema nonosum leprosum (ENL) or type II reaction is an immune 
complex syndrome seen in multibacillary leprosy 104. ENL usually occurs after 
specific treatment of lepromatous disease or borderline leprosy but may be 
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observed in patients who have not been treated. ENL presents with 
inflammatory skin nodules and involvement of multiple organs, often running a 
protracted course. Over one half of lepromatous patients and one quarter of 
borderline lepromatous patients will experience type 2 reaction105.  
 The clinical manifestation is of evanescent crops of tender erythematous 
papules or nodules located on interlesional skin. They are all dome shaped with 
ill defined margins. The papules may turn into pustules or may simply ulcerate. 
They can also occur as subcutaneous plaques. The lesions are most common on 
the face and extensor surface of limbs and less commonly on the trunk, 
accompanied by fever, malaise, arthralgia and leukocytosis. 
 Lesions tend to recur at the same sites and if they do not resolve 
completely, a chronic painful panniculitis develops which may persist for 
months or years. 
 Histopathology: In ENL, the lesions are foci of acute inflammation 
superimposed on chronic multibacillary leprosy106. It is characterized by edema 
of papillary dermis and a mixed dermal infiltrate of neutrophils and 
lymphocytes superimposed on collection of macrophages. There may be 
involvement of subcutis, with the development of mixed lobular and septal 
panniculitis. However, in majority of case involvement of the dermis is the 
primary and predominant finding. Macrophage in dermis contain fragmented 
organism. Polymorph neutrophils may be scanty or so abundant as to form a 
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dermal abscess with ulceration. Whereas foamy macrophages containing 
fragmented bacilli are usual, in some patients no bacilli remain and 
macrophages have a granular pink hue on Wade-Fite staining, indicating 
mycobacterial debris.  
Lesions exhibit necrotizing vasculitis involving capillaries, venules, and 
small-to-medium arteries and veins. In the superficial dermis, affected venules 
and capillaries showed endothelial cell enlargement and focal necrosis 
associated with perivascular infiltrates of lymphocytes.  
 In the deep dermis and subcutaneous tissue, affected venules, arterioles 
and arteries exhibited endothelial cell necrosis and matted fibrin in the vessel 
walls associated with perivascular infiltrates of neutrophils107. Throughout the 
dermis, mononuclear phagocytes with vacuoles containing numerous 
fragmented organisms were observed. These patients may have superficial 
ulceration106. 
Lucio phenomenon108,109,110 
 Lucio phenomenon is a vasculitis clinically described in 1852 and 
microscopically documented in 1948 in patients with diffuse lepromatous 
leprosy. Usually occurs in patients who have received either no treatment or 
inadequate treatment. In contrast to ENL, fever, tenderness and leukocytosis are 
absent. The lesions consists of barely palpable, hemorrhagic, sharply 
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marginated, irregular plaques. They develop into crusted lesions and, 
particularly on the legs, into ulcers.  
 Histopathologically, Lucio phenomenon is a distinctive type of 
granulomatous and necrotizing panvasculitis108 of small vessels in the upper and 
mid dermis that results in ulceration of epidermis. Occasionally the process 
extends deep into the subcutaneous fat with small vessel vasculitis in the fat 
lobule109. 
Septic Vasculitis 
 About 22% of all cases of cutaneous vasculitis are associated with 
infection, and all types of infectious agents (viruses, bacteria, fungi, protozoa 
and helminthes) have been associated with the development of vasculitis55, 56. 
The cutaneous pathology most often found in these cases is a small-vessel 
neutrophilic vasculitis affecting superficial dermal vessels.  
LCV histology found in infection-related vasculitis is likely A common 
morphologic endpoint of several pathways: Immune complex formation, 
alternate pathway of complement activation, and endotoxin-mediated 
expression of vascular adhesion molecules108, 109. In the case of Immune 
Complex formations, infection-triggered LCV is suspected to show a greater 
frequency of subcorneal, intraepidermal, and subepidermal neutrophilic 
pustules, to have more tissue neutrophilia and predominant IgA vascular 
23 
 
deposits, and to have relatively fewer eosinophils and lymphocytes than 
idiopathic CLA and drug-related cutaneous LCV 110.  
 Septic vasculitis is a variant of small-vessel neutrophilic vasculitis that is 
typically immune-complex negative and caused by infective endocarditis or 
septicemia from gonococci, meningococci, pseudomonads, staphylococci, 
streptococci, certain rickettsial infections, and other microorganisms55.  
The clinical lesions of septic vasculitis are characterized by purpura 
(petechiae and ecchymoses), vesiculo-pustules (often with gray roofs signifying 
necrosis), hemorrhagic bullae, and, rarely ulceration.  Patients with chronic 
gonococcemia and chronic meningococcemia have a triad of intermittent fever, 
arthralgia, and fewer clinical lesions, distributed over extremities, particularly 
acral surfaces, which are mostly petechiae surrounded by a rim of erythema 
vesiculo-pustules with a gray necrotic roof, and rarely hemorrhagic bullae.  
 Biopsy reveals mixed neutrophilic small and muscular-vessel vasculitis 
with deep dermal and subcutaneous vessel involvement associated with scant 
perivascular fibrin or fibrin thrombi, and no or little nuclear debris. These 
features help differentiate septic vasculitis from conventional CLA. 
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AIM OF THE STUDY 
 
1) To study the epidemiological spectrum of cutaneous small vessel 
vasculitides. 
 
 
2) To determine the clinicopathological correlation. 
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MATERIALS AND METHODS 
             A study was conducted during the period from May 2008 – May 
2010 in the department of dermatology,  Govt Rajaji Hospital,  Madurai 
Medical college, Madurai,  among the patients with cutaneous small 
vessel vasculitis attending  the dermatology department as well as those 
referred from other departments mainly Medicine,  Rheumatology  and  
paediatrics. 
Inclusion criteria: 
1. All patients with clinical features suggestive of small vessel vasculitis 
i.e palpable purpura ,  infiltrated erythema , hemorrhagic vesicles and 
bulla,  ulcers, infarct,  digital gangrene,  erythematous plaques and 
nodules, urticaria,  livedoreticularis which was subsequently supported 
by histopathological examination. 
Exclusioncriteria: 
1. Patients who were unwilling for the study 
2. Patients with abnormal bleeding parameters. 
A proforma was filled for all patients 
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History: 
  A detailed history was taken which includes, symptoms (itching , burning   
sensation,  pain) duration of skin lesions, occupational history,  systemic 
symptoms,  history of sore throat in the recent past,  history of drug intake, 
history suggestive of malignancy and collagen vascular disorders. 
 Clinical examination: 
Detailed general and systemic examinations were done.  Detailed  
examination  of  skin lesion which includes morphology of skin lesions,  
distribution of lesions,  symmetry, tenderness,  diascopy  were done. 
Investigations: 
1) Baseline laboratory investigations included are complete hemogram,  
serum urea,  serum creatinine, liver function tests , chest X ray,  urine 
(routine and microscopy),  Mantoux test, test for stool occult blood,  
ASO titre,  blood culture  and skin smears for acid fast bacilli,  USG 
Abdomen and pelvis . 
2) Screening for HIV, Hepatitis B, C and syphilis were also done  for 
high risk patients with history of sexual exposure or occupational 
exposure to blood and blood products. 
3) Tests to rule out cryoglobulinemia,  (cryoglobulin test , serum  protein 
electrophoresis,  complement ) malignancy and collagen vascular  
disorders were done when indicated. 
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4) Incisional elliptical skin biopsies were done from the early tender skin 
lesions with a caution  not to include the resolving lesion and they 
were sent to pathologist for histopahology Special stains like AFB 
were done  when required. 
5) Other tests to rule out bacterial infections include gram stain and 
blood culture.  
Classification of patients with features of cutaneous small vessel vasculitis in 
our study was  based on  Proposed  working  classification  of  vasculitis  
[updated   version  of  Gilliam’s  1976  scheme 12 . 
      Analysis : 
A descriptive analysis of the clinical characteristics,  laboratory 
parameters and histopathological  features of various cutaneous small vessel 
vasculitis  in our study was done.The data was analysed and compared with 
published literature. 
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OBSERVATION AND RESULTS 
 Fifty one patients with clinical features of cutaneous small vessel vasculitis 
were seen during the study period from May 2008 to May 2010. Of these, 11 
cases were excluded  from the study because of the patients denial for the study 
(4),  not willing for biopsy (7) .40 patients  were  diagnosed as cutaneous  small 
vessel vasculitis were included in our  study.  
Table -1 
 
Clinical spectrum of cutaneous small vessel vasculitis 
 
         
 
 
 
                                                                     
                                                                                     
                                                                                           
               
 
 
 
 
 
 
 
 
Cssv No.of patients Percentage(%) 
Henoch schonlein 
purpura (HSP) 
18 45 
Erythema nodosum 
leprosum (ENL)
10 25 
Collagen vascular 
disease vasculitis 
(CVDV) 
7 17.5 
Urticarial vasculitis 
(UV) 
2 5 
Septic vasculitis 
(SV) 
2 5 
Essential mixed 
cryoglobulinemic 
 Vasculitis(EMCV) 
1 2.5 
Total 40 100 
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  Key 
        Cssv  =  Cutaneous small vessel vasculitis 
The common types were Henoch schonlein purpura (18) ,  Erythema 
nodosum leprosum(10),  small vessel vasculitis  associated with collagen 
vascular disease (7).  The less common types were  urticarial vasculitis (2),  
septic vasculitis (2),   essential mixed cryoglobulinemia (1) 
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                 Table – 2 
                Sex distribution 
Disease Male Female 
No.of 
cases 
 % No.of 
cases 
 % 
HSP 
 
5 28 13 72 
ENL 
 
7 70 3 30 
CVDV 
 
1 14 6 86 
UV 
 
 
1 50 1 50 
SV 
 
 
- - 2 100 
EMCV 
 
1 100 - - 
Total 
 
15 38 25 62 
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   Key     
  HSP  = Henoch Schonlein  purpura                     
ENL   = Erythema nodosum leprosum  
CVDV  = Collagen vascular disease vasculitis               
           UV   = Urticaril vasculitis       
            SV  = Septic vasculitis 
          EMCV = Essential mixed cryoglobulinemic vasculitis  
There were 15 (38%) male and 25 (62%) female patients .  
 Male to female ratio is 1:1.7  
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  Table- 3 
  Age distribution 
Cssv 
 
<10 
Yrs 
10-20 
Yrs 
21-30 
Yrs 
31-40 
Yrs 
41-50 
Yrs 
51- 60 
Yrs 
>60 
Yrs 
Total 
HSP 
 
4 8 2 4    18 
ENL 
 
  2 4 3 1  10 
 
CVDV 
 1 4 1 1   7 
 
UV 
1  1     2 
 
SV 
2       2 
 
EMCV 
    1   1 
 
TOTAL 
7 9 9 9 5 1  40 
 
Key – Cssv = Cutaneous small vessel vasculitis    
          HSP =  Henoch Schonlein  purpura 
ENL = Erythema nodosum leprosum                
           UV = Urticaril vasculitis 
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SV  =        Septic vasculitis       Yrs = Years. 
           EMCV = Essential mixed cryoglobulinemic vasculitis  
Majority of patients were between the ages of 11 – 40 years. 
The mean age of our study group was 31 years  for males and 24 years for 
females. 
 Table -4 
Etiological factors  
Etiological factors 
 
No.of patients Percentage 
Infections 
 
22 55 
Drugs 
 
6 15 
Collagen vascular 
disorders 
 
7    17.5 
No cause  4 10 
 
Approximately twenty two ( 55%) of the patients had infections,  and seven        
( 17.5%)  had positive connective tissue disease workup without any overt 
manifestations,  six (15%) were attributed to  drugs ( These included NSAIDS 
in three,  antibiotics in two,  and unknown drugs in one patient). While one 
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(2.5%) patient  had cryoglobulinemia.  No cause was found in four (10%)  
cases. 
Table -5 
 Symtoms   
 
Itching  was the commonest presenting symptom in twelve (30%) patients.  six 
patients complained of fever (15%), while burning sensation and pain at the site 
of the lesion were encountered in four  and five patients respectively.  
 
 
 
Symptoms 
 
No.of patients Percentage (%)  
Itching 
 
12 30 
Fever 
 
6 15 
Pain at the site of lesion 
 
5 12.5 
Burning sensation 
 
4 10 
35 
 
Table – 6 
Systemic symptoms 
 
Systemic symptoms were encountered in 34 (85%) patients. Associated joint 
pains were the commonest systemic presentation in 19 (47.5%) patients with 
knee joint being the most commonly involved joint (11). Other joints involved 
were ankle joint and small joints of feet and wrists.  Joint swelling was observed 
in 5 patients. There was history of abdominal pain in 5 patients,  melena in 4 
Systemic symptoms 
 
No.of cases percentage   % 
Joint pain 
 
19 47.5 
Joint swelling 
 
5 12.5 
Pain abdomen 
 
5 12.5 
Melena 
 
4 10 
Hemoptysis 
 
1 2.5 
Total  
                   34 
                      
                  85 
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patients and hemoptysis in 1 patient . 
 Table – 7 
 Signs   
Signs 
 
No.of patients Percentage (%) 
Palpable purpura 
 
21 52.5 
Nodule 
 
7 17.5 
Plaque 
 
3 7.5 
Ulcers (crusted & necrotic) 
 
3 7.5 
Urticarial lesions 
 
2                   5 
Bulla 
 
1 2.5 
Ecchymoses 
 
1 2.5 
Pustule 
 
1 2.5 
Gangrene of digits 
 
1 2.5 
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Palpable purpura was the commonest cutaneous presentation noticed in 21 
patients (16 females and 5 males). The other cutaneous lesions seen in 19 
patients were in the form of nodules, plaques, ulcers, bullae, vesicles,  gangrene 
of toes,  urticarial lesions and Koebner phenomenon. The time since onset of 
lesions varied from 1 day to 9 months. 
 
Table- 8 
Distribution 
Region HSP ENL CVDV UV SV EMCV TOTAL % 
Face   -   3 1    4 10 
Trunk   3   8 2 2 1  16 40 
UL   7   3 3 1 1 1 16 40 
LL  18   3 5 2 1 1 30 75 
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Key 
  HSP    = Henoch Schonlein  purpura                     
 ENL    =  Erythema nodosum leprosum  
CVDV = Collagen vascular disease vasculitis               
           UV     = Urticaril vasculitis       
            SV    = Septic vasculitis 
          EMCV  = Essential mixed cryoglobulinemic vasculitis  
 LL  = Lower limb             UL = Upper limb 
The commonest sites  were lower limb (75 %) mainly the legs and anklle  
followed by upper limb,  trunk  and  face. 
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 Table – 9 
 Laboratory  findings 
 
Laboratory parameters No.of  patients Percentage (%) 
Anaemia  16 40 
Leukocytosis  12 30 
Raised ESR 27 67.5 
Elevated urea 6 15 
Elevated  serum creatinine 6 15 
Albuminuria 7 17.5 
Urine  examination    
RBC 7 17.5 
Pus cells - - 
Bacilli - - 
Stool for occult blood 8 20 
Abnormal chest x ray 1 2.5 
Anti nuclear antibody 5 12.5 
Rheumatoid factor 2 5 
ASO titre 10 25 
Mantoux test 1 2.5 
Hepatitis B Virus - - 
Hepatitis C Virus - - 
HIV - - 
Cryoglobulin Test 1 2.5 
USG abdomen – 
abnormality 
1 2.5 
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KEY 
ESR   =  Erythrocyte sedimentation rate                    
ASO titre   =   Anti streptolysin O titre 
RBC   =   Red blood cells                                                
 USG abdomen =  Ultrasonography abdomen 
HIV    =   Human immunodeficiency virus. 
 
The hematological and  biochemistry  workup  revealed anemia in sixteen 
(40%)patients,  leukocytosis in twelve(30%),  elevated ESR in twenty 
seven(67.5%),  raised serum-urea in six and raised creatinine levels in six 
patients. Routine urine examination showed albuminuria in seven patients, 
while urine microscopy demonstrated blood cells in seven patients.  The stool 
for occult blood was positive in eight patients. Chest x ray showing cavity in 
one  patient  with history of hemoptysis. Smear from pustular lesion in one 
patient  revealed  gonococci.  Blood culture from one patient with ecchymoses 
showed growth of Pseudomonas aeruginosa. Anti-nuclear antibody and 
rheumatoid factor were positive in five and two patients,  serum cryoglobulins 
were positive in one patient . ASO titer was also raised in ten patients, while 
Mantoux was positive in one patient. USG abdomen showed bowel wall edema 
in one patient with henoch schonlein pupura. 
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  Table - 10 
  Histopathology  
 
 
 
Clinical 
diagnosis 
No 
.of 
cases 
 
  % Histopathological 
diagnosis 
No. 
Of 
cases
  %        
NEV 
  %
HSP 
 
18 45 LCV 15 37.5 3 7.5 
ENL 10 25 LCV , mixed  
panniculitis 
8 20 2 5 
 
CVDV 
LE 
 
6 15 LCV 5 12.5 1 2.5 
RA 
 
1 2.5 LCV 1 2.5   
Urticarial  
Vasculitis 
2 5 LCV 2   5   
Septic vasculitis 
 
2 5 LCV 2   5   
Essential mixed 
cryoglobulinemic 
vasculitis 
1 2.5 LCV with hyaline 
thrombi 
1  2.5   
 
Total  
40 100  34  85 6   15
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Key – LCV = Leukocytoclastic vasculitis                  LE =Lupus erythematosus 
          NEV = No evidence of vasculitis                     RA = Rheumatoid arthritis 
          HSP = Henoch Schonlein purpura 
          ENL = Erythema nodosum leprosum 
         CVDV = Collagen vascular disease vasculitis 
 
Based on histopathological findings, 34 (85%) patients were given a diagnosis 
of leukocytoclastic vasculitis,  while  6 (15%)  patients showed perivascular 
lymphocytic infiltrates with no evidence of vasculitis. The skin biopsy showed 
typical features of endothelial swelling, fibrinoid necrosis, RBC extravasation 
and leukocytoclasis.  Additional findings include subepidermal bulla , Hyaline 
thrombi and mixed panniculitis were seen. 
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DISCUSSION 
  Cutaneous small vessel vasculitis is a poorly understood entity due to its 
protean clinical manifestation and its overlap with various infections, collagen 
vascular disorders and malignancies. In our study, we analyzed cases of 
cutaneous small vessel vasculitis diagnosed on the basis of history, clinical 
features, and various laboratory tests. The clinical diagnosis was supported by 
skin biopsy. Our study confirmed various established facts regarding cutaneous 
small vessel vasculitis and throws light on some new aspects. 
 One of the published study on cutaneous vasculitis was by Gupta et al112 
between 2004 -2006 Postgraduate Institute of Medical Education and Research, 
Chandigarh, India. They included 50 patients. The results of the study by Gupta 
et al 112 indicated that there were 20 male and 30 female patients. The mean age 
of the study group was 41.1 years for males and 35.9 years for females. In our 
study, 15(32%) were male and 25(62%) females. Females were more commonly 
affected than males in our study consistent with the study by Gupta et al.112 . 
The mean age of our study group was 31 years for males and 24 years for 
females in comparision with study by Gupta et al112. 
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Etiology 
 A possible etiological association was suspected in 90% of our patients 
which was comparable to 67.2% seen by Sais et al 111. Most common cause 
found in our study was infections 55%, mainly upper respiratory tract infections 
and this is consistent with study by Martinez-Taboada et al14 collagen vascular 
disorders (17.5%) and drugs (15%) were other causes of  cutaneous small vessel 
vasculitis in our study. Lupus erythematosus was the common collagen vascular 
disease found in our study. NSAIDS were the common drugs followed by 
antibiotics. This   was comparable with the results of the study by Sams et al 13, 
Callen et al15, Hautmann et al16.  
Symptoms  
The common symtoms observed in cutaneous lesions of our study were itching 
(30%), pain (12.5%) and burning sensation (10%). This was comparable with 
earlier studies by Sais et al111 where 41.3% patients complained of itching and 
30% had painful lesions. Fever was seen in 15% of our patients while it was 
31.6% in the study by Sais et al 111.  
Signs 
 The most common clinical presentation in our study was crops of 
nonthrombogenic palpable purpura, primarily involving dependent areas such as 
legs, ankles, feet and buttocks seen in 52.5% of   patients. This was comparable 
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with earlier studies by Sais et al111 ,  Ekenstam et al113, Gupta et al112 and Lopez 
Maturana et al116 in 89.2%,  62%, 86%  and 62% of cases, respectively. 
Koebner phenomenon was observed in two (5%) patients as reported in 
standard  literature34 . The second most common type of lesion in our study was 
cutaneous nodules which comprised 17.5% of patients as against 2% observed 
by Sais et al111.This may be due to high percentage of reactive leprosy in our 
study and high prevalence of multibacillary leprosy patients in India. 
Systemic involvement 
 Systemic involvement was observed in 87.5% of patients with the joint 
pain being the commonest presenting manifestation (52.5%).  This was again in 
consonance with the systemic involvement observed by Ekenstam et al113 in 
51% of patients where the musculoskeletal system was most commonly 
involved (43%). However Sais et al 111 observed systemic involvement only in 
20% of the cases with joint involvement in 36.7% of all cases. 
  Gastrointestinal involvement mainly in the form of abdominal pain, 
melena, occult blood in stools and bowel edema in Ultrasonography abdomen, 
was observed in 13(32.5%) patients which was consistent with 9.5% cases 
reported by Sais et al111. 
 Winkelmann and Ditto114 found renal involvement in 61% of their 
patients, while in our study, renal involvement was seen in only 11(27.5%) of 
patients. In our study renal involvement was seen in and collagen vascular 
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disorders in the form of elevated serum urea and creatinine, proteinuria and 
microscopic hematuria. In patients of Henoch Schonlein purpura with renal 
involvement, three had extensive cutaneous lesions all over the body while 
seven patients had musculoskeletal symptoms. This is consistent with study by 
Gupta et al112 where 16 % of cases had renal involvement, in that 3 had 
extensive cutaneous lesions, while 3 had musculoskeletal symptoms. 
 Pulmonary involvement was seen in only one case in the form of positive 
mantoux test and cavities (tuberculosis) in a patient of Henoch Schonlein 
purpura vasculitis. Tuberculosis was seen in (2.5 %) of our patients in contrast 
to no case detection in study by Sais et al 111 and Ekenstam et al 113. This was 
probably due to the high prevalence of tuberculosis in India. 
Laboratory findings 
 The laboratory parameters reflecting systemic inflammatory responses 
were elevated ESR in 27 (67.5%) patients, anemia in 16 (40%) and leukocytosis 
in 12(30%) patients. It was consistent with study by Sais et al111 where elevated 
ESR (52.4%), anemia (37%) and leukocytosis ( 18%) was observed.  
 The renal functions were altered in 6 (15%) patients in the form of 
elevated urea and creatinine and abnormal urine examination in 14 (35%) 
patients. Sais et al 111 found these parameters to be 26 and 21.1%, respectively. 
Liver function tests were within normal limits in all patients while Sais et al111 
observed elevated transaminase levels in 18% of patients. 
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 The collagen vascular disease workup revealed positive Anti nuclear 
antibodies in 12.5% and rheumatoid factor in 5% patients, which was in 
consistent with study results reported by Gupta et al 112 . In addition serum 
cryoglobulins were found positive in 1 (2.5%) patient consistent with study by 
Gupta et al in which 1(2%) patient had serum cryoglobulin. ASO titer was 
raised in 10 (25%) patients, while Mantoux test was positive in one (2.5%) of 
our patients.  Gupta et al 112   reported  ASO titre was found raised only one 
(2%) patient.  
Histopathology 
 Histopathology showed features of leukocytoclastic vasculitis in 34 
patients. In the remaining 6, perivascular lymphocytic infiltrate with no 
evidence of vasculitis was observed which was consistent with study by Gupta 
et al111 where out of 42 patients, 5 patients did not show evidence of vasculitis. 
Hence the diagnosis of cutaneous small vessel vasculitis was considered on the 
basis of high index of clinical suspicion. Moreover, histopathology was 
noncontributory in these cases, probably due to the biopsy of the lesion at a late 
stage in the disease evolution as mentioned in the literatue44-48. We found 25 % 
of patients with Erythema nodosum leprosum showing features of 
leukocytoclastic vasculitis in addition to mixed panniculitis as reported by Giam 
YC et al115. 
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SUMMARY 
40 patients,  diagnosed with cutaneous small vessel vasculitides, based on 
history, clinical features, laboratory findings, histopathology were included in 
the study. This study was done  for a period of 24 months ( May2008 to May 
2010) .   
Sex 
15 were male (38%) and 25 were female (62%). The male : female ratio 
was  1:1.7. 
Age 
Majority of patients were between the ages of  11 – 40 years. The mean 
age of  our  study  group was 31 years  for males and 24 years for females. 
. 
Clinical spectrum  
The common types of cutaneous small vessel vasculitis  included  
Henoch Schonlein purpura (45%),  Erythema nodosum leprosum (25%), 
connective tissue disorders with vasculitis (17.5%).  The less common types 
were urticarial vasculitis (5%),  septic vasculitis (5%) and  Essential mixed 
cryoglobulinemic vasculitis(2.5%). 
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Aetiology 
Infections(55%) mainly the upper respiratory tract infections  were the 
commonest underlying cause encountered in our study  followed by collagen 
vascular disorder (17.5%) and drugs (15%). 
Symptoms associated with skin lesions 
Itching was the predominant symptom noted in 30 % of patients followed 
by fever and burning sensation.  
Systemic symptoms 
Joint pain was the most common systemic symptom observed  in 47.5%  
of patients followed by joint swelling. In patients of  HSP  with renal 
involvement, three had extensive cutaneous lesions all over the body while 
seven patients had musculoskeletal symptoms. 
 Morphology & distribution 
The morphology of lesions and their distribution were concordant with 
those described in the literature . Clinically most of the patients presented with 
palpable purpura in the dependent parts especially the legs. Legs involvement  
and palpable purpura were noted in 100% of cases of  Henoch Schonlein 
purpura. Koebner phenomenon was observed in two patients. 
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Laboratory findings 
Common laboratory findings observed were  elevated ESR(67.5%), and  
anemia  (40%) . 
Histopathology 
 Leukoocytoclastic vasculitis was the most common histopathological 
pattern observed in 34 cases.We found a significant proportion(25%) of patients 
with ENL presenting as leukocytoclastic vasculitis in addition to mixed 
panniculitis. 
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CONCLUSION 
1. Henoch Schonlein purpura was the most common cutaneous small vessel 
vasculitis followed by Erythema nodosum leprosum. 
2. Cutaneous small vessel vasculitis was more common in females. 
3. Majority of the patients were between 11 – 40 years of age. 
4. Upper respiratory tract infection was the commonest  etiologic factor in 
cutaneous small vessel vasculitis. 
5. Joint pain was the common systemic symptom found in majority of 
patients. 
6. Nonthrombogenic palpable purpura  represents clinical hallmark in 
cutaneous small vessel vasculitis.  
7. Widespread cutaneous manifestations may be the  cutaneous marker of  
serious systemic involvement. 
8.  Elevated ESR and anemia were the common laboratory abnormalities. 
9. Leukocytoclastic vasculitis was the common histopathological pattern in 
cutaneous small vessel vasculitis. 
10. Significant proportion of patients with Erythema nodosum Leprosum 
presenting as leukocytoclastic vasculitis . 
11. Early biopsy and Clinicopathological correlation is necessary for the 
diagnosis of cutaneous small vessel vasculitis. 
 
 
KEY TO MASTER CHART 
Morphology 
1 = Palpable purpura 
2 = Nodules 
3 = Plaques 
4 = Nodules and plaques 
5 = Ulcer 
6 = Urticaria 
7 = Gangrene 
8 = Pustules 
9 = Bulla with / without ulcer 
10 = Ecchymoses 
DSL = Duration of skin lesions 
Symptoms 
1 = Burning sensation 
2 = Itching 
3 = pain  
4 = Fever 
Systemic symptoms 
1 = Joint pain 
2 = Joint swelling 
3 = Melena 
4 = Abdominal pain 
5 = Diarrhoea 
6 = Hemoptysis 
Drugs 
1 = NSAIDS (Non steroidal anti inflammatory drugs) 
2 = Antibiotics 
3 = Unknown 
Region 
1 = Lower limb 
2 = Lower limb and trunk 
3 = lower limb, trunk and upper limb 
4 = Lower limb and upper limb 
ASO titre = Anti Streptolysin O titre 
Urine routine 
1 = Hematuria 
2 = Proteinuria 
3 = Hematuria and Proteinuria 
 
RFT = Renal function test 
1 = Elevated urea and creatinine 
LFT  = Liver function test 
RF  = Rheumatoid factor 
ANA  = Anti nuclear antibody 
CRGT  = Cryoglobulin test 
CXR  = Chest X ray 
       Cavt = Cavity 
MX  =  Mantoux test 
USG Abdomen = Ultrasonography of Abdomen 
B.E = Bowel wall edema 
SSS  = Slit skin smear 
CD  = Clinical diagnosis 
HSP  = Henoch Schonlein purpura 
LEV  = Lupus erythematosus with vasculitis 
RAV  = Rheumatoid arthritis with vasculitis 
ENL  = Erythema nodosum leprosum 
UV  = Urticarial vasculitis 
SV  = Septic vasculitis 
EMCV = Essential mixed cryoglobulinemic vasculitis 
HP  = Histopathology 
LCV  = Leukocytoclastic vasculitis 
MP  = Mixed panniculitis 
NEV  = No evidence of vasculitis 
P  = Positive 
N  = Negative 
NRL  = Normal 
F  = Female 
M  = Male 
Y  = Years 
M  = Months 
D  = Days 
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1 Deepika 12y/F 1 2w 2 1 P _ 3 P P 3 1 NRL N N N NRL N N NRL P P P _ HSP LCV
2 Arul pondi 19y/M 1 3M 2 4 _ _ 3 P P 3 1 NRL N N N NRL N N B.E P _ P _ HSP LCV
3 Sumathy 28y/F 2 2M _ 1 _ _ 1 _ _ _ NRL NRL N N N NRL N N NRL _ P P P ENL LCV, MP
4 Arumugam 50y/M 7 15D _ _ _ _ 4 _ _ _ NRL NRL P N P NRL N N NRL _ _ P _ EMCV LCV
5 Baby of Gayathiri 15D /F 8 5D 4 2 _ _ 4 _ _ _ NRL NRL N N N NRL N N NRL P _ P _ SV LCV
6 Abdul Majeet 45y/M 2 6M _ _ _ _ 3 _ _ _ NRL NRL N N N NRL N N NRL _ _ P P ENL LCV, MP
7 Dinesh Kumar 9y/M 1 1D 4 1 P _ 1 P P _ NRL NRL N N N NRL N N NRL P P _ _ HSP NEV
8 Deepa 18y/F 1 1M 4 1 _ _ 1 _ _ 2 1 NRL N P N NRL N N NRL _ P P _ LEV LCV
9 Bhuvana 7 y/F 1 1D _ 1 P _ 1 P _ 1 NRL NRL N N N NRL N N NRL P _ P _ HSP LCV
10 Perumal 50y/M 2 6M _ 0 _ _ 3 _ _ _ NRL NRL N N N NRL N N NRL P _ _ P ENL LCV, MP
11 Alagu 48y/M 5 1M 3 1 _ _ 3 _ _ 2 1 NRL N P N NRL N N NRL _ _ P _ LEV LCV
12 Priya 3y/F 10 2D _ _ _ _ 1 _ _ _ NRL NRL N N N NRL N N NRL P _ P _ SV LCV
13 Praveen 7 y/M 6 15D 1 4 _ _ 4 _ _ _ NRL NRL N N N NRL N N NRL _ _ P _ UV LCV
14 Kavitha 6 y/F 1 7D 2 2 P _ 2 P P _ NRL NRL N N N NRL N N NRL P _ _ _ HSP NEV
15 Angayarkanni 28y/M 5 6M 3 1 _ _ 1 _ _ _ NRL NRL N N N NRL N N NRL _ P P _ LEV LCV
16  Eswar 40y/M 4 9M 3 _ _ _ 1 _ _ _ NRL NRL N N N NRL N N NRL P P _ P ENL NEV
17 Pondiammal  40y/F 9 9M _ 2 _ _ 1 _ _ _ NRL NRL P P N NRL N N NRL P P _ _ RAV LCV
18 Angammal 35 y/F 1 6M 2 6 _ 3 2 _ _ 1 NRL NRL N N N Cavt  P N NRL _ _ _ _ HSP LCV
19 Karthick 40y/M 1 3D 2 3 _ 2 1 _ P _ NRL NRL N N N NRL N N NRL _ _ P P HSP NEV
20 Panchavarnam 23y/F 2 3M _ 1 _ _ 3 _ _ _ NRL NRL N N N NRL N N NRL _ _ _ P ENL  LCV, MP
Name
MASTER CHART 




Henoch schonlein purpura
Erythema nodosum leprosum
Collagen vascular disease vasculitis
Urticarial vasculitis
Septic vasculitis
Essential mixed cryoglobulinemic
vasculitis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Clinical Spectrum 
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PROFORMA 
• Name               
• Age           
• Sex                  
• Hosp.No                                                     
• Occupation   
• Presenting complaint          
• Duration of skin lesions      
• Precipitating factors   
Drugs                                  
Infection(sore throat)     
Trauma                              
•  Symptoms           
Fever   
Pain                                  
Burning sensation          
Itching                              
Symmetrical                            
Site, Description               
• Systemic symptoms     
Joint pain    
Joint swelling    
Melena      
Abdominal pain    
Diarrhoea    
Hemoptysis    
• General Examination 
Weight     
Temperature 
Pallor                    
Lymphadenopathy  
• Type of skin lesion     
Purpura 
Nodule 
Plaque 
Ulcer 
Urticaria 
Gangrene 
Pustule  
Bulla 
Ecchymoses 
• Systemic examination 
CVS     
RS     
CNS     
GIT     
• Investigations 
ASO titre    
Stool occult blood   
Urine examination   
Complete hemogram  
 Hb (gm%)    
 TC    
 DC     
 ESR                                             
 Platelet count                                              
Diascopy          
LFT                                                    
RFT                         
ANA                                                   
RF            
Cryoglobulin test                              
Chest x ray                                         
Mantoux test                                     
Viral markers (Hep B , C and HIV)  
USG Abdomen              
Slit skin smear for AFB                      
Skin Biopsy                                          
Special stain                                        
• Histopathological findings 
• Final diagnosis                                 
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